We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bristol-Myers Squibb Pharmaceutical Limited

Watery Lane, Swords, Co. Dublin,
Telephone: 1 800 749 749
Medical Information Direct Line: Freephone: 1 800 749 749
Medical Information e-mail: Medical.information@bms.com
Patient Information Leaflet last updated on medicines.ie: 06/04/2017
PIL Adcortyl Intra-articular / Intradermal Injection 10mg/ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 06/04/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision
Updated on 31/03/2016 and displayed until 06/04/2017
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 18/06/2014 and displayed until 31/03/2016
Reasons for adding or updating:
  • Change to side-effects
  • Addition of information on reporting a side effect.
Updated on 19/02/2014 and displayed until 18/06/2014
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 03/02/2014 and displayed until 19/02/2014
Reasons for adding or updating:
  • Change to storage instructions
  • Addition of information on reporting a side effect.
Updated on 25/05/2012 and displayed until 03/02/2014
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 22/02/2012 and displayed until 25/05/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to date of revision
  • Change to MA holder contact details
  • Change due to user-testing of patient information
Updated on 24/08/2009 and displayed until 22/02/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 19/08/2008 and displayed until 24/08/2009
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Triamcinolone Acetonide